PortfoliosLab logoPortfoliosLab logo
ULBI vs. MSTR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ULBI vs. MSTR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ultralife Corporation (ULBI) and Strategy Inc (MSTR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ULBI achieves a 20.72% return, which is significantly higher than MSTR's -16.72% return. Over the past 10 years, ULBI has underperformed MSTR with an annualized return of 4.85%, while MSTR has yielded a comparatively higher 20.96% annualized return.


ULBI

1D
-2.88%
1M
4.31%
YTD
20.72%
6M
22.21%
1Y
-4.76%
3Y*
14.67%
5Y*
-5.76%
10Y*
4.85%

MSTR

1D
-7.01%
1M
-31.15%
YTD
-16.72%
6M
-32.83%
1Y
-67.34%
3Y*
61.19%
5Y*
21.16%
10Y*
20.96%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ULBI vs. MSTR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ULBI
Ultralife Corporation
20.72%-23.22%9.24%76.68%-36.09%-6.65%-12.45%9.48%3.05%32.32%
MSTR
Strategy Inc
-16.72%-47.53%358.54%346.15%-74.00%40.13%172.42%11.65%-2.70%-33.49%

Correlation

The correlation between ULBI and MSTR is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (10Y)
Calculated over the trailing 10-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Jun 12, 1998

0.15

The correlation between ULBI and MSTR shifts across timeframes, from 0.15 (all time) to 0.27 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ULBI:

$115.02M

MSTR:

$42.26B

EPS

ULBI:

-$0.49

MSTR:

-$40.19

PS Ratio

ULBI:

0.61

MSTR:

79.33

PB Ratio

ULBI:

0.89

MSTR:

1.15

Total Revenue (TTM)

ULBI:

$187.86M

MSTR:

$490.47M

Gross Profit (TTM)

ULBI:

$43.39M

MSTR:

$334.08M

EBITDA (TTM)

ULBI:

$6.73M

MSTR:

$466.93M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ULBI vs. MSTR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ULBI
ULBI Risk / Return Rank: 3737
Overall Rank
ULBI Sharpe Ratio Rank: 3737
Sharpe Ratio Rank
ULBI Sortino Ratio Rank: 3737
Sortino Ratio Rank
ULBI Omega Ratio Rank: 3737
Omega Ratio Rank
ULBI Calmar Ratio Rank: 3737
Calmar Ratio Rank
ULBI Martin Ratio Rank: 3737
Martin Ratio Rank

MSTR
MSTR Risk / Return Rank: 66
Overall Rank
MSTR Sharpe Ratio Rank: 55
Sharpe Ratio Rank
MSTR Sortino Ratio Rank: 33
Sortino Ratio Rank
MSTR Omega Ratio Rank: 66
Omega Ratio Rank
MSTR Calmar Ratio Rank: 77
Calmar Ratio Rank
MSTR Martin Ratio Rank: 1010
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ULBI vs. MSTR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ultralife Corporation (ULBI) and Strategy Inc (MSTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ULBIMSTRDifference

Sharpe ratio

Return per unit of total volatility

-0.08

-0.96

+0.88

Sortino ratio

Return per unit of downside risk

0.30

-1.75

+2.05

Omega ratio

Gain probability vs. loss probability

1.04

0.81

+0.22

Calmar ratio

Return relative to maximum drawdown

-0.11

-0.88

+0.77

Martin ratio

Return relative to average drawdown

-0.17

-1.31

+1.13

ULBI vs. MSTR - Sharpe Ratio Comparison

The current ULBI Sharpe Ratio is -0.08, which is higher than the MSTR Sharpe Ratio of -0.96. The chart below compares the historical Sharpe Ratios of ULBI and MSTR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ULBIMSTRDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.08

-0.96

+0.88

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.10

0.23

-0.33

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.09

0.29

-0.20

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.03

0.12

-0.15

Drawdowns

ULBI vs. MSTR - Drawdown Comparison

The maximum ULBI drawdown since its inception was -92.90%, smaller than the maximum MSTR drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for ULBI and MSTR.


Loading charts...

Drawdown Indicators


ULBIMSTRDifference

Max Drawdown

Largest peak-to-trough decline

-92.90%

-99.86%

+6.96%

Max Drawdown (1Y)

Largest decline over 1 year

-44.69%

-76.53%

+31.84%

Max Drawdown (3Y)

Largest decline over 3 years

-68.83%

-77.42%

+8.59%

Max Drawdown (5Y)

Largest decline over 5 years

-68.83%

-84.11%

+15.28%

Max Drawdown (10Y)

Largest decline over 10 years

-68.83%

-89.27%

+20.44%

Current Drawdown

Current decline from peak

-71.82%

-73.29%

+1.47%

Average Drawdown

Average peak-to-trough decline

-63.48%

-86.48%

+23.00%

Ulcer Index

Depth and duration of drawdowns from previous peaks

27.26%

51.59%

-24.33%

Volatility

ULBI vs. MSTR - Volatility Comparison

Ultralife Corporation (ULBI) has a higher volatility of 25.54% compared to Strategy Inc (MSTR) at 19.43%. This indicates that ULBI's price experiences larger fluctuations and is considered to be riskier than MSTR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ULBIMSTRDifference

Volatility (1M)

Calculated over the trailing 1-month period

25.54%

19.43%

+6.11%

Volatility (6M)

Calculated over the trailing 6-month period

41.68%

56.49%

-14.81%

Volatility (1Y)

Calculated over the trailing 1-year period

58.55%

70.30%

-11.75%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

59.02%

90.79%

-31.77%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

55.19%

73.70%

-18.51%

Dividends

ULBI vs. MSTR - Dividend Comparison

Neither ULBI nor MSTR has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ULBI vs. MSTR - Financials Comparison

This section allows you to compare key financial metrics between Ultralife Corporation and Strategy Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00M40.00M60.00M80.00M100.00M120.00M140.00M20222023202420252026
47.45M
124.30M
(ULBI) Total Revenue
(MSTR) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ULBI and MSTR have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ULBI has higher volatility (25.54%) compared to MSTR (19.43%). In terms of maximum drawdown, ULBI dropped -92.90% vs MSTR's -99.86%.

ULBI currently has the higher Sharpe Ratio (-0.08 vs -0.96), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ULBI and MSTR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer